AlphAIalphai — Financial news for AI agents
SEC EDGARAUG 181 min read$BRKR

Pusch Wolfgang sold $198K of BRKR

Pusch Wolfgang (President BMID Group) sold 3,473 shares of BRUKER CORP (BRKR) at $56.90 ($0.20M total) on 2026-08-17.

Original reporting
SEC EDGAR · Pusch Wolfgang
Published Aug 18, 2026, 8:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 18, 2026, 8:46 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$BRKR
Neutral
medium confidence
Mentioned
$BRKR
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BRKRNeutralLow
01

Why it matters

The newest fact is the specific open-market sale details by an officer (President, BMID Group) on 2026-08-17, filed on 2026-08-18.

02

Market read

Traders may note insider selling, but the disclosed dollar value is small and there is no accompanying fundamental catalyst.

03

What to watch

The filing does not indicate a 10b5-1 plan, but it also provides no context on motivations or whether other insiders are buying/selling.

Relevance 4/10Novelty 3/10Timing: filed 2026-08-18, transaction dated 2026-08-17

Background

The article is an SEC Form 4 insider transaction disclosure for Bruker Corp (BRKR).

Company-level read

Ticker impact

$BRKRNeutralMedium confidence
Context

Form 4 shows Pusch Wolfgang sold 3,473 BRKR shares in an open-market sale for about $197.6K.

Expected impact

Likely minimal near-term impact; any effect is more about signaling than new fundamentals.

Evidence & confidence

The filing is a disclosed transaction size of roughly $0.2M and lacks any accompanying corporate event, guidance, or operational change.

Market effects

Sector

No clear sector read-through from a single small insider sale.

Regional

None.

Global

None.

Counterpoint

What could challenge this read

Insider sales can be driven by diversification, taxes, or pre-existing personal liquidity needs rather than bearish expectations.

Key entities

  • issuer
    BRUKER CORP

    Subject of the Form 4 insider transaction disclosure.

  • insider
    Pusch Wolfgang

    President, BMID Group, reported an open-market sale of BRKR shares.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

BRKR insider trading history →

Related articles

AUG 19
$AVTRMed

Q2 Earnings Highs And Lows: Thermo Fisher (NYSE:TMO) Vs The Rest Of The Research Tools & Consumables Stocks

Avantor (AVTR) reported Q2 revenue of $1.69B, flat YoY, beating estimates by 4.9%, with stock up 8.2%. Bruker (BRKR) reported $838.5M revenue, up 5.2% YoY, missing estimates by 1.9%, with stock down 11.6%. Sotera Health (SHC) reported $321.4M revenue, up 9.2% YoY, beating estimates by 3.8%, with stock up 2.9%. Bio-Techne (TECH) reported $321.2M revenue, up 1.3% YoY, beating estimates by 2%, with stock flat.

yahoo.com3 min
AUG 11
$BRKRMedAI 8/10

Bruker (BRKR) Q2 2026 Earnings Call Transcript

Bruker (BRKR) reported Q2 2026 revenue of $838.5 million, up 5.2% year over year, with organic growth of 2.8% (3.4% excluding U.S. tariff refund impacts). Non-GAAP gross margin was 52.1% and non-GAAP EPS $0.49. FY2026 guidance: revenue $3.54B to $3.57B and non-GAAP EPS $2.10 to $2.15.

fool.com6 min
AUG 5
$BRKRMedAI 8/10

Bruker Reports Second-Quarter 2026 Results as Scientific Instruments Bookings Accelerate

Bruker (NASDAQ:BRKR) reported Q2 2026 revenue of $838.5M, up 5.2% (organic growth 2.8%). Scientific Instruments bookings rose 10% organically with a book-to-bill above 1.0x. Non-GAAP EPS increased to $0.49; GAAP results included a non-cash goodwill impairment. Bruker kept 2026 non-GAAP EPS guidance at $2.10-$2.15 and updated revenue guidance to $3.54B-$3.57B for currency and tax effects.

yahoo.com6 min
AUG 4
$BRKRMedAI 8/10

Bruker (BRKR) Stock Trades Down, Here Is Why

Bruker (BRKR) shares fell 17.7% after the company reported Q2 results. Adjusted EPS of $0.49 beat estimates, but revenue was $838.5 million, below expectations. Bruker also cut full-year revenue guidance to a $3.56 billion midpoint, below analysts’ forecasts, driving the selloff despite the earnings beat.

financialcontent.com3 min